Drug interactions
Fenofibrate micronized + Glimepiride-pioglitazone
Severity: Minor
Fenofibrate micronized and Glimepiride-pioglitazone: minor interaction.
Last updated
For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.
Summary
Fenofibrate may modestly enhance the glucose-lowering effect of antidiabetic agents. Pioglitazone is metabolized by CYP2C8, which fibrates may inhibit weakly, and fibrates may also improve insulin sensitivity. The clinical effect is generally small.
What this interaction means in plain words
Fenofibrate micronized and Glimepiride-pioglitazone have a small, usually unimportant interaction. Most people can take both; the pharmacist may still mention it so that any unexpected effect is recognised.
Why it happens
Possible protein-binding displacement or weak CYP2C8 inhibition plus additive improvements in insulin sensitivity; mechanism not firmly established.
What to do
No dose adjustment is usually required; monitor blood glucose after starting or stopping fenofibrate.
What to ask your pharmacist
- Is there anything I should notice while taking both?
- Do I need to tell my doctor at the next visit?
Pro+ members
Unlock the full page
Create an account and start a Pro+ trial to unlock the full management advice for Fenofibrate micronized and Glimepiride-pioglitazone, the additional notes, the evidence detail and the whole-prescription interaction checker.
- Full clinical management advice
- Additional notes
- Evidence detail
- Interaction checker for a whole prescription
Try Pro+ free for 14 days on the web. No card needed.
Other interactions of Glimepiride-pioglitazone
Frequently asked questions
Can I take Fenofibrate micronized with Glimepiride-pioglitazone?
MediHelp rates the interaction as minor. Fenofibrate micronized and Glimepiride-pioglitazone have a small, usually unimportant interaction. Most people can take both; the pharmacist may still mention it so that any unexpected effect is recognised. Fenofibrate may modestly enhance the glucose-lowering effect of antidiabetic agents. Pioglitazone is metabolized by CYP2C8, which fibrates may inhibit weakly, and fibrates may also improve insulin sensitivity. The clinical effect is generally small.
How serious is the interaction between Fenofibrate micronized and Glimepiride-pioglitazone?
MediHelp rates it minor, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: No dose adjustment is usually required; monitor blood glucose after starting or stopping fenofibrate.
What other medicines interact with Glimepiride-pioglitazone?
MediHelp also lists interactions of Glimepiride-pioglitazone with, for example, Fluconazole, Gemfibrozil, Insulin aspart. The full list is on the Glimepiride-pioglitazone page.
Full monographs, dosing and an interaction checker in the MediHelp app
Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.
